Premium
Perivascular scaffolds loaded with adipose tissue‐derived stromal cells attenuate development and progression of abdominal aortic aneurysm in rats
Author(s) -
Parvizi M.,
Petersen A. H.,
van SpreuwelGoossens C. A. F. M.,
Kluijtmans S. G. J. M.,
Harmsen M. C.
Publication year - 2018
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.36445
Subject(s) - elastin , extracellular matrix , stromal cell , adipose tissue , inflammation , abdominal aortic aneurysm , aorta , aortic aneurysm , abdominal aorta , pathology , medicine , cancer research , microbiology and biotechnology , aneurysm , biology , immunology , cardiology , surgery
Abdominal aortic aneurysm (AAA) is the pathological dilation and weakening of the abdominal aorta wall. Inflammation, degradation of the extracellular matrix (ECM) and loss of smooth muscle cells and skewing of their function are pivotal in AAA pathology. We developed a recombinant collagen‐based patch (RCP) to provide structural integrity and deliver Adipose tissue‐Derived Stromal Cells (ASC) for repair. Patches supported adhesion and function as well as proliferation of ASC. ASC‐loaded RCPs or bare patches, applied around the aorta after AAA induction in rats, both maintained structural integrity of the aortic wall at time of explant (2w). However, wall thinning, accompanied by loss of elastin fibers and loss of medial SMC, was only attenuated in ASC‐loaded RCP‐treated AAA rats. Interestingly, this coincided with migration of ASC into the media and a reduced influx of macrophages. We hypothesize that the medially‐migrated ASC dampened or skewed the adverse innate immunity and thus suppressed SMC apoptosis, phenotypic skewing and elastin degradation. We conclude that the periadventitial delivery of ASC with RCP suppresses development and progression of AAA, which is has an expected future clinical benefit in combination with an appropriate early screening program of patients at risk for aneurysms. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A:2494–2506, 2018.